APA (7th ed.) Citation

Prevo, R., Fokas, E., Reaper, P. M., Charlton, P. A., Pollard, J. R., McKenna, W. G., . . . Brunner, T. B. (2012). The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer biology & therapy, 13(11), 1072-1081. https://doi.org/10.4161/cbt.21093

Chicago Style (17th ed.) Citation

Prevo, Remko, Emmanouil Fokas, Philip M. Reaper, Peter A. Charlton, John R. Pollard, W. Gillies McKenna, Ruth J. Muschel, and Thomas B. Brunner. "The Novel ATR Inhibitor VE-821 Increases Sensitivity of Pancreatic Cancer Cells to Radiation and Chemotherapy." Cancer Biology & Therapy 13, no. 11 (2012): 1072-1081. https://doi.org/10.4161/cbt.21093.

MLA (9th ed.) Citation

Prevo, Remko, et al. "The Novel ATR Inhibitor VE-821 Increases Sensitivity of Pancreatic Cancer Cells to Radiation and Chemotherapy." Cancer Biology & Therapy, vol. 13, no. 11, 2012, pp. 1072-1081, https://doi.org/10.4161/cbt.21093.